Orthopaedic Oncology Market Overview
Orthopaedic oncology refers to the diagnosis and treatment of primary benign and malignant tumors of the bones and soft tissues. Orthopaedic oncology tumors include Ewing sarcoma, osteosarcoma, and other malignancies which involve the musculoskeletal system. Orthopaedic oncology represents a very small share in othropaedic. Orthopaedic oncology treatment includes surgery, chemotherapy, radiation therapy and targeted therapy.
Market Size and Forecast
Global orthopaedic oncology market is expected to grow at a significant CAGR during the forecast period i.e. 2017-2024. Factors such as rising prevalence of cancer and strong growth in healthcare sector in developing nations are anticipated to foster the growth of the global orthopaedic oncology market during the forecast period. Moreover, new products and development of advanced treatment methods is expected to bolster the sales of the orthopaedic oncology products.
In the regional market, North America is anticipated to dominate the overall market of orthopaedic oncology during the forecast period. High prevalence of cancer and rapid ageing geriatric population is expected to benefit the growth of orthopaedic oncology market. Apart from this, increasing spending on healthcare and high awareness is anticipated to impel the growth of the orthopaedic oncology market over the forecast period. Europe orthopaedic oncology market is expected to witness substantial growth over the forecast period. Rising penetration of cancer and musculoskeletal related disorders signals promising growth for orthopaedic oncology market in the region. Further, precision oncology is gaining momentum in gaining momentum in European countries and is anticipated to benefit the growth of the orthopaedic oncology market in the years ahead.
Moreover, Asia Pacific ranks as the fastest growing region in orthopaedic oncology market. Growing healthcare infrastructure and rise in the spending on medical treatment is predicted to trigger the growth of the orthopaedic oncology market in the next few years. Countries such as China, Japan, South Korea and India are witnessing augmented demand for orthopaedic oncology products.CLICK TO DOWNLOAD FREE SAMPLE
Based on treatment, orthopaedic oncology market is segmented into surgery, chemotherapy, radiation therapy and targeted therapy, out of which, surgery segment is expected to dominate the overall orthopaedic oncology market during the forecast period.
Market Segmentation
Our-in depth analysis of the global orthopaedic oncology market includes the following segments:
By Treatment
- Surgery
- Amputation
- Limb Salvage Surgery
- Reconstructive Surgery
- Chemotherapy
- Radiation Therapy
- Targeted Therapy
By End User
- Hospitals
- Research Laboratories
By Region
The global orthopaedic oncology market is further classified on the basis of region as follows:
- North America (United States, Canada), Market size, Y-O-Y growth Market size, Y-O-Y growth & Opportunity Analysis, Future forecast & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
Growth Drivers and Challenges
Increasing prevalence of musculoskeletal oncology is the major factor which is expected to intensify the growth of the orthopaedic oncology market. Further, rapid growth in ageing population in various developed nations is anticipated to positively impact the demand for orthopaedic oncology treatment during the forecast period. Apart from this, high growth in the number of new cases diagnosed in the past few years is expected to trigger the growth rate of global orthopaedic oncology market. Increasing healthcare expenditure and rising per capita income of the population is anticipated to positively impact the growth of the global orthopaedic oncology market.
Favorable government initiatives and policies to limit the number of deaths from musculoskeletal cancer are anticipated to foster the growth of the global orthopaedic oncology market during the forecast period. Furthermore, rising number of multispecialty and cancer hospitals across the globe are envisioned to bolster the growth of global orthopaedic oncology market.
The market stands to benefit from increasing number of research and development activities. Moreover, development of precision oncology is offering profitable opportunities for the growth of the global orthopaedic oncology market.
However, costly and complicated treatment therapies are a major stumbling block for the growth of orthopaedic oncology market. Lack of awareness about bone and musculoskeletal malignancies among the population is anticipated to negatively impact the growth of the global orthopaedic oncology market. Moreover, strict approval regulations are also slowing down the growth of orthopaedic oncology market.
Top Featured Companies Dominating The Market
- Stryker Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Amgen Inc.
- Creganna Medical Group
- Accentus Inc.
- Canon Medical Systems
- Siemens Healthineers
- MD Anderson Cancer Center
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Sanofi S.A.
